Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Gynecol Oncol. 2022 Jul;166(1):76-84. doi: 10.1016/j.ygyno.2022.05.007. Epub 2022 May 17.
To examine postoperative complications associated with preoperative mechanical and oral antibiotic bowel preparation (MOABP) for patients with ovarian cancer who underwent bowel resection at cytoreductive surgery (CRS).
This was a single-institution retrospective study of patients with ovarian cancer undergoing CRS from 01/2011-12/2020 using ICD-10 diagnoses and procedure codes. Patients were stratified by those who underwent bowel resection versus no resection. Bowel resection patients were further stratified by those who underwent MOABP versus no bowel preparation. Patient demographics, tumor data, and perioperative metrics were collected. Unadjusted and adjusted logistic regression evaluated odds of 30-day postoperative complications in patients with bowel resection versus no resection and those with MOABP versus no bowel preparation.
Of 919 patients identified, 215 (23.3%) required bowel resection, which included 81 (37.7%) who received MOABP. Patient characteristics, co-morbidities, and cancer data were similar between MOABP versus no bowel preparation patients. MOABP patients underwent more interval CRS (34.6% versus 9.0%), more optimal surgical resections (96.3% versus 83.8%), fewer diverting ostomies (13.5% versus 33.5%), and shorter hospital stays (7.1 versus 9.4 days) than no bowel preparation patients. On adjusted analyses, MOABP patients experienced significantly lower odds of deep/organ-space surgical infections and 30-day readmissions but higher odds of unplanned intensive care unit (ICU) admissions and grade 3 or higher cardiac and gastrointestinal complications.
Patients who underwent preoperative MOABP prior to ovarian cancer CRS with bowel resection had lower odds or deep/organ-space infections and readmissions, shorter hospital stays, fewer diverting ostomies, and more optimal resections. However, these patients also experienced higher odds of ICU admissions and grade 3 or higher cardiac and gastrointestinal complications. The positive and negative postoperative outcomes in this population should be considered in clinical practice.
研究接受细胞减灭术(CRS)的卵巢癌患者术前机械性和口服抗生素肠道准备(MOABP)与术后并发症的关系。
这是一项单中心回顾性研究,纳入了 2011 年 1 月至 2020 年 12 月期间接受 CRS 的卵巢癌患者,通过 ICD-10 诊断和手术代码进行分层。患者分为行肠道切除术和不行肠道切除术两组。行肠道切除术的患者再分为行 MOABP 和不行肠道准备两组。收集患者的人口统计学、肿瘤数据和围手术期指标。采用未调整和调整后的逻辑回归评估行肠道切除术患者与不行肠道切除术患者、行 MOABP 患者与不行肠道准备患者发生 30 天术后并发症的几率。
在 919 例患者中,有 215 例(23.3%)需要行肠道切除术,其中 81 例(37.7%)接受了 MOABP。MOABP 组与无肠道准备组患者的患者特征、合并症和癌症数据相似。MOABP 患者行更多次间隔性 CRS(34.6%比 9.0%)、更理想的手术切除(96.3%比 83.8%)、更少的转流性造口术(13.5%比 33.5%),以及更短的住院时间(7.1 天比 9.4 天)。调整分析显示,MOABP 患者发生深部/器官间隙手术感染和 30 天再入院的几率显著降低,但 ICU 入院和 3 级或更高级别心脏和胃肠道并发症的几率更高。
在卵巢癌 CRS 并肠道切除术的患者中,术前接受 MOABP 的患者发生深部/器官间隙感染和再入院的几率较低,住院时间较短,转流性造口术较少,手术切除更理想。然而,这些患者发生 ICU 入院和 3 级或更高级别心脏和胃肠道并发症的几率更高。在临床实践中,应该考虑到该人群的这些阳性和阴性术后结果。